Results 141 to 150 of about 27,883 (236)

Post‐Market Analysis of the Xenios Console With the Xlung Tubing Kit 230 for Extracorporeal Membrane Oxygenation After Cardiac Surgery

open access: yesArtificial Organs, Volume 50, Issue 10, Page 1464-1475, October 2026.
This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci   +9 more
wiley   +1 more source

Supportive Outpatient‐Provider Communication—A Scoping Review About Expectations, Experiences, and Actual Behaviours Regarding Healthcare Visits

open access: yesJournal of Evaluation in Clinical Practice, Volume 32, Issue 7, October 2026.
ABSTRACT Rationale Twenty‐first century healthcare has struggled with chronic illnesses while policies have emphasised patient centeredness and support. The importance of ambulatory visits and self‐management necessitate understanding about supportive outpatient‐provider communication.
Sari Knaapi‐Junnila   +2 more
wiley   +1 more source

Incidence and Determinants of Implantable Cardioverter-Defibrillator Therapy With Loss of and Impaired Consciousness. [PDF]

open access: yesPacing Clin Electrophysiol
Noordman ABP   +5 more
europepmc   +1 more source

QT Interval Evaluation in Right Ventricular Pacing: Validation of a Novel Formula

open access: yesPacing and Clinical Electrophysiology, Volume 49, Issue 10, Page 1455-1463, October 2026.
ABSTRACT Background QT interval measurement in the presence of right ventricular pacing (RVP) represents a clinical challenge. We therefore aimed to derive and validate a formula for QT estimation during RVP in a large cohort of pacemaker patients. Methods and Results We prospectively enrolled 100 patients in a derivation cohort and 487 in a validation
Amr Abdin   +9 more
wiley   +1 more source

Safety and Performance of INVICTA DF4 Ventricular Defibrillation Lead: Results From APOLLO Prospective Multicenter Study

open access: yesPacing and Clinical Electrophysiology, Volume 49, Issue 10, Page 1595-1603, October 2026.
ABSTRACT Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy